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Why was the cohort set up?
Proportions of malnourished mothers and children remain
high, especially in South Asia.1 In countries like India,
Pakistan and Bangladesh, underweight and stunted linear
growth frequently start in fetal life. This is reflected in a
high proportion of children who are small for their gesta-
tional age at birth and experience continued stunted
growth.2–4 A life cycle perspective is needed to address
these intergenerational problems.1,5
Trials that have provided pregnant women in under-
nourished populations with balanced protein-energy sup-
plementations demonstrated increased birthweight.6 Most
food supplementation programmes have reached pregnant
women in mid or late pregnancy6 for practical reasons. In
the first trimester, organs develop and fetal plasticity is
pronounced. A balanced dietary intake including micronu-
trients is needed beginning in the first trimester, to ensure
fetal health, growth and later health.7–10
To prevent anaemia and promote fetal health, the
World Health Organization has recommended iron-folate
supplementation during pregnancy. Based on the notion
that iron and other micronutrient deficiencies often coex-
ist, a group of experts developed the composition of a
multiple-micronutrient supplement for trial purposes.11
A series of prenatal multiple micronutrient trials were initi-
ated in different countries, with maternal haemoglobin and
birthweight as outcomes.12
Nutritional imbalance or insult in fetal or early life may
alter later disease risk. This concept, later labelled the
Developmental Origin of Health and Disease (DOHaD),
has been underpinned by epidemiological and biomedical
studies.13–15 Few prenatal nutritional intervention studies
have been done, however, to assess the effect of prevention
of nutritional imbalance or insult on developmental trajec-
tories at a stage when developmental plasticity is great.16
Based on these considerations, the designers of the
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(MINIMat, ClinicalTrials.gov identifier ISRCTN16581394)
hypothesized that prenatal multiple-micronutrient supple-
mentation (MMS), as well as an early invitation (around ges-
tational week 9) to receive a daily food supplement, would
increase maternal haemoglobin concentration at 30 weeks’
gestation, birthweight, and infant survival. The designers also
hypothesized that a combination of these interventions (early
invitation with MMS) would further improve these outcomes
compared with the usual timing of invitation to food supple-
mentation (around week 20) and supplementation with the
standard programme of iron-folic acid supplements.
At an early stage in the planning of the MINIMat co-
hort, the perspective that events in early fetal life might
have longer-term consequences provided a rationale for a
long-term follow-up. Secondary outcomes listed at the
time of the trial registration were: child growth and cogni-
tive development; child micronutrient status; child immune
function and morbidity; blood pressure; metabolic
markers; and mothers’ anthropometric development up to
the next pregnancy, when applicable.
The trial was carried out in Matlab, Bangladesh, a rural
sub-district 57 km south of the capital Dhaka, a setting where
child and maternal undernutrition remain widespread. In this
area, the International Centre for Diarrhoeal Disease
Research, Bangladesh (iccdr, b) has been running a Health and
Demographic Surveillance System (HDSS) since 1966.
Through monthly household visits, community health research
workers (CHRW) collect data on demographic and selected
health information, on a population of about 220 000 in more
than 140 villages. The use of a unique identification system
allows tracking over time and across studies and databases.
The initial funding of the MINIMat trial (up to birth)
was provided by the United Nations Children’s Fund
(UNICEF), followed by many funders, as described
below.
Who is in the cohort?
Participants were recruited from 11 November 2001 to 30
October 2003 (Figure 1). CHRW visited all households
monthly. If a woman of reproductive age reported that her
last menstrual period (LMP) was overdue or that she was
pregnant, she was offered a pregnancy test and the date of
her LMP was recorded. A woman who tested positive was
encouraged to visit the icddr, b clinic, where an ultrasound
examination was offered. Dating based on ultrasound ex-
amination at week 8 was used if LMP date was missing
Women were eligible for the study if they had a viable fetus
and gestational age less than 14 weeks on ultrasound, no se-
vere illness and provided written consent for participation.
In total, 5880 women were assessed for eligibility, 1444
were excluded, and 4436 women were randomized to the
different nutrition interventions. There were 3625 live
births. The MINIMat cohort study and the Health and
Demographic Surveillance System in the area have closely
monitored these children.
The MINIMat trial participants were randomized into
six groups in a 3 x 2 design. A double-masked supplemen-
tation with capsules of 30 mg iron and 400mg of folic acid,
60 mg of iron and 400mg of folic acid or multiple micronu-
trients (MMS) containing a daily allowance of 15 micronu-
trients, including 30 mg of iron and 400mg of folic acid,
was combined with food supplementation (608 kcal/day
on 6 days per week) randomized to either early invitation
(9 weeks’ gestation) or usual invitation (20 weeks’ gesta-
tion). Primary outcomes were maternal haemoglobin con-
centration at 30 weeks’ gestation, birthweight, gestational
age at birth and infant mortality. The pregnant women
who participated in the MINIMat trial were also randomly
allocated in the third trimester to receive either the usual
health messages from the antenatal services or to receive
exclusive breastfeeding counselling.
At baseline, the pregnant women in this cohort had an
average weight of 45 kg and mean height of 150 cm,17 see
Table 1. One-third of these women were in their first
Figure 1. Study flow.
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pregnancy and four out of 10 were in their third or later
pregnancies. One-third had no formal education, and
slightly more than half had attended school for 5 years or
more. One-quarter had some surplus in the perceived sta-
tus of income compared with expenditure, and one-fifth
had some deficit. The attrition during the follow-up period
did not change the general characteristics and proportions
allocated to the different interventions of the population
being studied, see Table 1.
How often have they been followed up?
After recruitment at around gestational week 8, women
were assessed at gestational weeks 9, 14, 19 and 30
(measurements listed in Table 2). Mothers and newborn
children were assessed at birth, followed by monthly exami-
nations of the dyads up to 12 months. During the second
year of life, the children were assessed quarterly. The next
follow-ups were performed at 4.5 and 10 years of age.
At 12.3 to 14.5 years of age, assessments of pubertal devel-
opment, anthropometry and body composition were
performed.
Of the 5880 pregnant women who were initially
assessed, 4436 were eligible and consented to participate in
the trial (Figure 1). These women had 3625 live births, of
which 3560 were singleton live births. For the follow-up at
4.5 years of age, 2851 children participated (80% of the
single live births). For the follow-up at 12.3–14.5 years of
Table 1. Background characteristics of the pregnant women at recruitment, for those with a live birth, and for those where the
child also participated at follow-up at 12–14 years. MINIMat cohort, Bangladesh, 2001–17
Characteristic Levels Recruitment Live birth 12-14 years
(n 3625) (n 2307)
Total 4415 3587 2306
Age at recruitment <20 711 (16) 563 (16) 331 (14)
20–29 2521 (57) 2067 (57) 1312 (57)
>30 1183 (27) 957 (27) 663 (29)
4416 3619 2307
Parity First 1479 (33) 1184 (33) 662 (29)
Second or more 2937 (67) 2435 (67) 1645 (71)
Total 4462 3580 2300
BMI kg/m2 <18.5 1228 (28) 1000 (28) 669 (29)
>18.5 3234 (72) 2580 (72) 1631 (71)
Total 4431 3591 2307
Educational level No schooling 1427 (32) 1135 (32) 795 (34)
1–4 years 479 (11) 400 (11) 298 (13)
5 or more years 2525 (57) 2506 (57) 1214 (53)
Total 4431 3591 2307
Household asset score at recruitment Lowest third 1476 (33) 1195 (33) 821 (36)
Middle 1483 (34) 1209 (34) 812 (35)
Highest third 1472 (33) 1187 (33) 674 (29)
Total 4429 3589 2305
Household surplus at recruitment Surplus 1199 (27) 976 (27) 585 (25)
Equal 2367 (53) 1917 (53) 1254 (54)
Occasional deficit 727 (16) 586 (16) 393 (17)
Constant deficit 125 (3) 102 (3) 66 (3)
Don’t know 11 (0.2) 8 (0.2) 7 (0.3)
Total 4436 3625 2307
Trial randomizationa EþFe30 739 (16.7) 608 (16.8) 389 (16.9)
EþFe60 738 (16.6) 610 (16.8) 387 (16.8)
EþMMS 740 (16.7) 595 (16.4) 404 (17.5)
UþFe30 741 (16.7) 605 (16.7) 374 (16.2)
UþFe60 738 (16.6) 612 (16.9) 387 (16.8)
UþMMS 740 (16.7) 595 (16.4) 366 (15.9)
Data are n/n (%).
BMI, body mass index; U¼ start of food supplementation at the standard programme start (week 20); Fe30¼ 30 mg Fe with 400 mg folic acid; Fe60¼60 mg Fe
with 400 mg folic acid; MMS¼15 micronutrients including 30 mg Fe and 400 mg folic acid.
aE¼Early invitation to daily prenatal food supplementation (gestational week 9).
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age, 2307 children participated (64% of the singleton live
births). Out-migration and unavailability because of other
activities were the main explanations for non-participation
by these schoolchildren. Children who did not attend the
latest follow-up more frequently came from wealthier
households (asset score in the highest tertile, 42% lost to
follow up, as compared with the lower two tertiles with
31% attrition). They also more frequently had mothers
with some formal education (37% attrition) in comparison
with children of mothers with no formal schooling (30%
attrition).
What has been measured?
This cohort was established within the Matlab HDSS,
which implies that the cohort data may be linked to family,
Table 2. Measurements in the MINIMat trial and follow-up
Pregnancy Birth 0–24 months 4.5 years 10 years 12–14 years
Interventions
Compliance food supplementation þ
Compliance micronutrients (eDEM) þ
Anthropometry etc.
Gestational age (LMP, ultrasound) þ
Maternal anthropometry þ þ þ þ þ
Fetal growth (ultrasound) þ
Child anthropometry þ þ þ þ þ
Skinfolds, body composition þ þ þ
Child development
Motor and cognitive development þ þ þ
Language development þ þ
Motor milestones þ
Mother-child interaction þ
IQ þ þ
Home environment þ þ þ
Infections, immune function
Morbidity þ þ þ þ þ
Thymus size (ultrasound) þ
Food, diet, feeding
Food security þ þ þ þ þ
Diet þ þ þ
Diet diversity þ þ
Breastfeeding þ þ
Reproductive history
Previous pregnancies, outcomes þ
Follow-up to next pregnancy þ þ
Social conditions
Household asset score þ þ þ þ
Parents’ education þ
Parents’ occupation þ þ þ
Marital status
Partner violence þ þ
Depressive symptoms/distress þ þ þ
Biomarkers
Haematology þ þ þ þ
Micronutrients þ þ þ þ
Oxidative stress þ
Toxic exposure (urine) þ þ þ þ
Metabolic markers þ þ
Blood pressure þ þ þ
Salivary cortisol þ þ
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sociodemographic and reproductive information on moth-
ers and grandmothers if these relatives stayed within the
Matlab HDSS the years before. Valid data on important
demographic and health-related events are available, such
as last menstrual period, date of birth, out-migration, in-
migration, death and causes of death.
The pregnancy cohort was followed from about gesta-
tional week 9 (Table 1). Fetal growth was monitored by re-
peated ultrasound assessments. Infant and young child
anthropometric measurements were carefully monitored up
to 2 years of age and after that at ages 4.5 and 10.0 years.
Body composition was assessed by bioelectrical impedance
measurements at 4.5, 10.0 and 12.3–14.5 years of age.
The quality of maternal-infant interaction was mea-
sured at 4 months of age. Child development was assessed
when the participants were 7 and 18 months as well as 5
and 10 years old. These assessments included Bayley Scales
of Infant Development, behaviour ratings, language devel-
opment, IQ and motor milestones.
Morbidity was assessed by 7-day recalls throughout in-
fancy up to 2 years of age, and after that at 4.5 and
10 years of age. At 8, 24 and 52 weeks of age, thymic vol-
ume was assessed by ultrasound.
The social conditions of the members of the MINIMat
cohort have been carefully and repeatedly assessed. These
indicators include household characteristics (including as-
set scores), food security, educational level of parents and
a wide range of characteristics of the mother and the child.
Participating women also responded to questions regarding
exposure to physical, sexual and emotional violence and
levels of controlling behaviour. Women’s levels of stress
were measured.
Haemoglobin has been measured repeatedly in mothers
and their children. In sub-samples, assessments have been
made of iron and other micronutrient status, markers of
oxidative stress, toxic exposure including arsenic, meta-
bolic markers and salivary cortisol (Table 2).
What has been found? Key findings and
publications
To date, more than 100 scientific publications and 20 PhD dis-
sertations have been completed based on data from the
MINIMat cohort. See [http://www.kbh.uu.se/Research/Internati
onalþChildþHealthþandþNutrition/main-fields-of-research-
and-projects/global-nutrition] for a complete publication list.
There was a pronounced effect on infant survival in line
with the hypothesis. With early invitation to food supple-
mentation with MMS, this group had an infant mortality
rate of 16.8 per 1000 live births, versus 44.1 per 1000 live
births among the group with the usual later invitation to
food supplementation with 60 mg of iron and 400mg of folic
acid [hazard ratio (HR) 0.38, 95% confidence interval (CI)
0.18–0.78], Figure 2.17 Adjusted maternal haemoglobin
concentrations at 30 weeks’ gestation were 115.0 g/L with
no differences among treatment groups. Mean birthweight
was 2694 g with no difference among groups. An equity
analysis revealed that the intervention reduced the gap in
child survival between social groups.18 The interventions
were also judged to be cost-effective in reducing mortality.19
The early invitation to food supplementation in pregnancy
reduced the occurrence of stunting at 0–54 months of age.20
In contrast, prenatal MMS increased the proportion of
stunting,20 a finding that also was supported by correspond-
ing IgF1 levels.21
The prenatal supplementations had also effects on met-
abolic markers at 4.5 years of age.21 These effects were
judged to be of public health importance and suggest pro-
gramming effects in early fetal life.
What are the main strengths and
weaknesses?
The MINIMat cohort is a well-characterized cohort with in-
formation from early pregnancy to puberty. Plans are under
way for a new update at 15 years of age. The randomized
prenatal food and micronutrient interventions have enabled
analyses of short- and medium-term effects and will provide
opportunities to address the question whether long-term
(adulthood) negative consequences of early nutritional
insults may be prevented by this type of prenatal inter-
vention. The context of this cohort is characterized by
Figure 2. Infant deaths per 1000 live births in the MINIMat trial with 95%
confidence intervals. E¼ early (around week 9) invitation to daily balanced
food supplementation, 600kcal, 6days per week; U¼ the usual timing
(around week 20) of start of this food supplementation; Fe30Fol¼ 30mg
iron and 400mg of folic acid; Fe60Fol¼ 60mg of iron and 400mg of folic
acid; MMS¼multiple micronutrients containing a daily allowance of 15
micronutrients, including 30mg of iron and 400mg of folic acid.
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widespread undernutrition of mothers and children, and al-
most two-thirds of these children were born small for their
gestational-age. This is important to consider when making
inferences to other low-income settings. There was no
follow-up between 5 and 10 years. For some rare outcomes,
the sample size may be too small.
Can I get hold of the data? Where can I find
out more?
Several researchers and research groups have so far
analysed MINIMat data to address new research questions
that could be answered by the available databases. If you
are interested, please contact Qazi Sadeq-ur Rahman at
[qsrahman@icddrb.org].
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